Collectively, the exacerbated steatosis and insulin resistance along with the enhanced inflammatory profile suggest that NRK1 LKO progressed towards a more advanced stage of NAFLD. This evidence concerns the gene NMRK1 and metabolic dysfunction-associated steatotic liver disease.